clinical pharmacology

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Pharmacology Trial ([14C]LP-168)

Not yet recruiting
  • Clinical Pharmacology
  • (no location specified)
Nov 13, 2023

Clinical Pharmacology, Pharmacokinetics, Cardiovascular Diseases Trial in Dallas (CRD-740, Itraconazole)

Recruiting
  • Clinical Pharmacology
  • +3 more
  • Dallas, Texas
    Cardurion Investigative Site
Jul 12, 2022

Clinical Pharmacology Trial in Neuss (Finerenone (BAY 94-8862) PEG solution, Finerenone (BAY 94-8862) immediate release tablet,

Completed
  • Clinical Pharmacology
  • Finerenone (BAY 94-8862) PEG solution
  • +3 more
  • Neuss, Nordrhein-Westfalen, Germany
    (unnamed)
Jan 27, 2022

Clinical Pharmacology Trial in Sumida-ku, Fukuoka, Kumamoto (Rivaroxaban (BAY 59-7939, Xarelto) in ODT form, Rivaroxaban (BAY

Completed
  • Clinical Pharmacology
  • Rivaroxaban (BAY 59-7939, Xarelto) in ODT form
  • Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form
  • Sumida-ku, Tokyo, Japan
  • +2 more
Aug 12, 2020

Clinical Pharmacology Trial in Sumida-ku, Fukuoka, Kumamoto (Rivaroxaban (BAY 59-7939, Xarelto) in ODT form, Rivaroxaban (BAY

Completed
  • Clinical Pharmacology
  • Rivaroxaban (BAY 59-7939, Xarelto) in ODT form
  • Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form
  • Sumida-ku, Tokyo, Japan
  • +2 more
Aug 12, 2020

Clinical Pharmacology Trial in Kiel (Riociguat (Adempas, BAY 63-2521))

Completed
  • Clinical Pharmacology
  • Riociguat (Adempas, BAY 63-2521)
  • Kiel, Schleswig-Holstein, Germany
    (unnamed)
Apr 25, 2020

Clinical Pharmacology Trial in Kiel (Riociguat (Adempas, BAY 63-2521))

Completed
  • Clinical Pharmacology
  • Riociguat (Adempas, BAY 63-2521)
  • Kiel, Schleswig-Holstein, Germany
    (unnamed)
Apr 25, 2020

Clinical Pharmacology Trial in San Antonio (Naproxen sodium and diphenhydramine HCl soft capsules, Naproxen sodium and

Completed
  • Clinical Pharmacology
  • Naproxen sodium and diphenhydramine hydrochloride soft capsules
  • Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)
  • San Antonio, Texas
    ICON Development Solutions, LLC
Mar 19, 2019

Clinical Pharmacology Trial in Secaucus (Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG),

Completed
  • Clinical Pharmacology
  • Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)
  • Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)
  • Secaucus, New Jersey
    Frontage Clinical Services
Sep 18, 2018

Clinical Pharmacology Trial in Secaucus (Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG),

Completed
  • Clinical Pharmacology
  • Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)
  • Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)
  • Secaucus, New Jersey
    Frontage Clinical Services
Sep 12, 2018

Clinical Pharmacology Trial in Neu-Ulm (B12019 and Neulasta)

Completed
  • Clinical Pharmacology
  • B12019 and Neulasta
  • Neu-Ulm, Germany
    Nuvisan GmbH
Oct 12, 2017

Clinical Pharmacology Trial in Wuppertal (Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) +

Completed
  • Clinical Pharmacology
  • Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetil
  • Wuppertal, Nordrhein-Westfalen, Germany
    (unnamed)
Apr 28, 2017

Clinical Pharmacology Trial in Fukuoka (Fosrenol ODT (Lanthanum Carbonate, BAY77-1931), Fosrenol chewable Tablet (Lanthanum

Completed
  • Clinical Pharmacology
  • Fosrenol ODT (Lanthanum Carbonate, BAY77-1931)
  • Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)
  • Fukuoka, Japan
    (unnamed)
Mar 20, 2017

Clinical Pharmacology Trial in Sumida-ku (TAK-114 10 mg capsule, TAK-114 matched )

Completed
  • Clinical Pharmacology
  • TAK-114 10 mg capsule
  • TAK-114 matched placebo
  • Sumida-ku, Tokyo, Japan
    (unnamed)
Jun 13, 2016

Clinical Pharmacology Trial in Fukuoka-shi (SYR-322-MET)

Completed
  • Clinical Pharmacology
  • Fukuoka-shi, Fukuoka, Japan
    (unnamed)
Jun 4, 2015

Clinical Pharmacology Trial in Kumamoto-shi (TAK-233, Placebo)

Completed
  • Clinical Pharmacology
  • Kumamoto-shi, Kumamoto, Japan
    (unnamed)
Oct 20, 2014